Toll free

18002022232

Access. Ensured.

Dignity. Enabled.

Care. Delivered.

Dedicated to bridging the gap in healthcare for individuals and families living with blood disorders and cancers. We believe that every patient whether a child or an adult deserves access to life-saving treatments without the burden of financial hardship or lack of infrastructure.
Support Our Mission
"Where science makes cure possible, humanity must make it accessible."

Our Mission

To deliver comprehensive, accessible care to children and adults with hematological and oncological disorders through appropriate timely treatment, research, community outreach, and compassionate clinical programs irrespective of financial capacity.

Our Vision

To ensure equitable access for every patient with blood disorders or cancer to timely, high-quality, and affordable treatment, developed and delivered within India and beyond, free from economic and geographic barriers.

Our Commitment to Patients and Families

“We are dedicated to ensuring that every child and adult affected by blood disorders and cancer who reaches us receives appropriate, compassionate, and timely care”.
Patient Support
  • Providing routine services and clinical support for blood disorders and cancers in adults and children at SunAct Khar and Thane.
  • Offering hematopoietic stem cell transplantation (HSCT) and other medical interventions.
  • Guiding families through the long-term management of chronic blood disorders and oncological conditions, while providing psycho-social and logistical support at every step of the journey.
Healthcare Access
  • Collaborating with government bodies, hospitals, and NGOs.
  • Partnering with CSR initiatives to support patient care.
  • Building networks to ensure patients can access affordable treatments when they need them most.

Founding Leadership

Dr. Mamta Manglani

Director, Pediatric Hematology-Oncology & Bone Marrow Transplant

One of India’s leading experts in pediatric hematology-oncology and bone marrow transplantation, with decades of experience across leading public institutions. She anchors the Foundation’s clinical approach in rigor, compassion, and long-term patient outcomes, ensuring every intervention meets the highest standards of care.

KNOW MORE

Dr. Vijay Patil

Co-Founder & Senior Medical Oncologist

A senior medical oncologist with over two decades of experience in advanced cancer care and systemic therapies. As a co-founder, he plays a central role in strengthening the Foundation’s clinical capabilities and advancing the adoption of next-generation treatments, with a strong focus on patient outcomes and evidence-based care.

KNOW MORE

Kushagra Sharma

Co-Founder & Executive Director

An experienced healthcare leader working at the intersection of therapeutics, healthcare delivery, and scalable system design to expand access to advanced cancer care in India. With over two decades of experience building data-driven and large-scale platforms, he focuses on translating scientific innovation into affordable, real-world patient impact, in close collaboration with clinical leaders.

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male